1. Home
  2. OGN vs RAMP Comparison

OGN vs RAMP Comparison

Compare OGN & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.70

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
RAMP
Founded
1923
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
OGN
RAMP
Price
$13.43
$37.70
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$11.40
$35.60
AVG Volume (30 Days)
2.6M
2.1M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
22500.00
EPS
0.55
2.24
Revenue
$6,216,000,000.00
$812,940,000.00
Revenue This Year
$0.45
$11.18
Revenue Next Year
$1.67
$9.09
P/E Ratio
$24.42
$16.85
Revenue Growth
N/A
9.03
52 Week Low
$5.69
$21.71
52 Week High
$13.49
$37.92

Technical Indicators

Market Signals
Indicator
OGN
RAMP
Relative Strength Index (RSI) 72.03 75.61
Support Level $10.05 $37.24
Resistance Level $13.46 $37.92
Average True Range (ATR) 0.05 0.19
MACD -0.11 -0.31
Stochastic Oscillator 57.14 73.53

Price Performance

Historical Comparison
OGN
RAMP

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

Share on Social Networks: